TY - JOUR
T1 - Paradigm shift in early detection
T2 - Lung cancer screening to comprehensive CT screening
AU - Mulshine, James L.
AU - Pyenson, Bruce
AU - Healton, Cheryl
AU - Aldige, Carolyn
AU - Avila, Riccardo S.
AU - Blum, Torsten
AU - Cham, Matthew
AU - de Koning, Harry J.
AU - Fain, Sean B.
AU - Field, John K.
AU - Flores, Raja
AU - Giger, Maryellen L.
AU - Gipp, Ilya
AU - Grannis, Frederic W.
AU - Gratama, Jan Willem C.
AU - Kazerooni, Ella A.
AU - Kelly, Karen
AU - Lancaster, Harriet L.
AU - Montuenga, Luis
AU - Myers, Kyle J.
AU - Naghavi, Morteza
AU - Osarogiagbon, Raymond
AU - Pastorino, Ugo
AU - Reeves, Anthony P.
AU - Rizzo, Albert
AU - Ross, Sheila
AU - Schneider, Victoria
AU - Seijo, Luis M.
AU - Shaham, Dorith
AU - Silva, Mario
AU - Smith, Robert
AU - Taioli, Emanuela
AU - ten Haaf, Kevin
AU - van der Aalst, Carlijn M.
AU - Viola, Lucia
AU - Vogel-Claussen, Jens
AU - Walstra, Anna N.H.
AU - Wu, Ning
AU - Yang, Pan Chyr
AU - Yip, Rowena
AU - Yankelevitz, David F.
AU - Henschke, Claudia I.
AU - Oudkerk, Matthijs
N1 - Publisher Copyright:
© 2025
PY - 2025/3/11
Y1 - 2025/3/11
N2 - Large-scale lung cancer screening implementation combined with improvements in early detection techniques for three major tobacco-related diseases presents a rare opportunity to markedly improve population health outcomes for millions of people. Chest CT enables routine detection of early lung cancer as well as characterizing coronary calcium and detecting early emphysema in the course of lung cancer screening. Integrated preventive care centered on comprehensive chest CT screening has the potential to bring large benefits across co-morbid diseases with a common etiology. The current one-disease/ silo paradigm of medical practice is an obstacle to maximizing chest CT screening's benefits. The large potential for improved health outcomes across the world demands careful public health, quality assurance, and health policy considerations. A systematic analysis of imaging and health data from ongoing chest CT screening could accelerate this paradigm shift through sustained optimization of screening detection, quantitation and management for the three most lethal tobacco-related co-morbidities. To coordinate this effort to advance progress with implementing the full benefit of comprehensive chest CT screening, a new multi- disciplinary professional and advocacy consortium has been developed to foster collaboration to realize the future of multi-disease chest CT screening.
AB - Large-scale lung cancer screening implementation combined with improvements in early detection techniques for three major tobacco-related diseases presents a rare opportunity to markedly improve population health outcomes for millions of people. Chest CT enables routine detection of early lung cancer as well as characterizing coronary calcium and detecting early emphysema in the course of lung cancer screening. Integrated preventive care centered on comprehensive chest CT screening has the potential to bring large benefits across co-morbid diseases with a common etiology. The current one-disease/ silo paradigm of medical practice is an obstacle to maximizing chest CT screening's benefits. The large potential for improved health outcomes across the world demands careful public health, quality assurance, and health policy considerations. A systematic analysis of imaging and health data from ongoing chest CT screening could accelerate this paradigm shift through sustained optimization of screening detection, quantitation and management for the three most lethal tobacco-related co-morbidities. To coordinate this effort to advance progress with implementing the full benefit of comprehensive chest CT screening, a new multi- disciplinary professional and advocacy consortium has been developed to foster collaboration to realize the future of multi-disease chest CT screening.
KW - Chest CT scan
KW - Chronic obstructive pulmonary disease
KW - Coronary artery disease
KW - Emphysema
KW - Lung cancer
KW - Lung cancer screening
KW - Quantitative imaging
UR - http://www.scopus.com/inward/record.url?scp=85216639249&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2025.115264
DO - 10.1016/j.ejca.2025.115264
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 39904127
AN - SCOPUS:85216639249
SN - 0959-8049
VL - 218
JO - European Journal of Cancer
JF - European Journal of Cancer
M1 - 115264
ER -